Parkinson’s is a debilitating condition with no cure or treatments to slow its progression. EJS-ACT-PD is a pioneering clinical trial platform that will test multiple drugs at once, speeding up the search for urgently needed treatments.
Categories
Beneficiaries
Parkinson’s is a progressive neurological condition affecting over 166,000 individuals in the UK. Despite extensive research, there is still no treatment that can slow or stop its progression, and current therapies only manage symptoms. Our mission is to find a cure, faster. Traditional trials are slow and costly, often focusing on single treatments. We’re working to accelerate the discovery of new treatments by supporting a smarter, faster approach.
Traditionally, every time a new drug can be tested, a clinical trial must be developed from scratch (protocol, infrastructure, recruitment, and funding). It’s like rebuilding a football stadium every time you want to play a match. What’s needed is a smarter approach: EJS ACT-PD is a Multi-Arm Multi-Stage platform trial that allows for the assessment of several potential therapies simultaneously against a single placebo, reusing the same infrastructure to increase the pace of scientific progress.
